Voss Capital, LP - 14 Nov 2025 Form 4 Insider Report for Rein Therapeutics, Inc. (RNTX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Nov 2025, 17:30:44 UTC
Prior SEC filing
12 Nov 2025
Next SEC filing
07 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Voss Capital, LP; By: /s/ Travis W. Cocke, Managing Member

Key filing fact

Voss Capital, LP filed Form 4 for Rein Therapeutics, Inc. (RNTX) on 18 Nov 2025.

Key facts

  • This page summarizes Voss Capital, LP's Form 4 filing for Rein Therapeutics, Inc. (RNTX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Nov 2025, 17:30.

Change

  • Previous filing in this sequence was filed on 12 Nov 2025.
  • Current net transaction value: +$127,593.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (5)

CIK 0001730145 Primary reporting owner

Voss Capital, LP

Relationship
10%+ Owner
Address
3773 RICHMOND AVENUE, SUITE 850, HOUSTON
Signature
Voss Capital, LP; By: /s/ Travis W. Cocke, Managing Member
Signature date
18 Nov 2025
CIK 0001969435

Voss Value Master Fund, LP

Relationship
10%+ Owner
Address
3773 RICHMOND AVENUE, SUITE 850, HOUSTON
Signature
Voss Value Master Fund, LP; By: Voss Advisors GP, LLC; By: /s/ Travis W. Cocke, Managing Member
Signature date
18 Nov 2025
CIK 0001863498

Voss Value-Oriented Special Situations Fund, LP

Relationship
10%+ Owner
Address
3773 RICHMOND AVENUE, SUITE 850, HOUSTON
Signature
Voss Value-Oriented Special Situations Fund, LP; By: Voss Advisors GP, LLC; By: /s/ Travis W. Cocke, Managing Member
Signature date
18 Nov 2025
CIK 0001798309

Voss Advisors GP, LLC

Relationship
10%+ Owner
Address
3773 RICHMOND AVENUE, SUITE 850, HOUSTON
Signature
Voss Advisors GP, LLC; By: /s/ Travis W. Cocke, Managing Member
Signature date
18 Nov 2025
CIK 0001798383

Cocke Travis W.

Relationship
10%+ Owner
Address
3773 RICHMOND AVENUE, SUITE 850, HOUSTON
Signature
/s/ Travis W. Cocke
Signature date
18 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RNTX transaction

Common Stock, $0.001 par value

Purchase

Transaction value
$127,593
Shares
+104,183
Change %
+13%
Price
$1.22
Shares after
926,441
Date
14 Nov 2025
Ownership
By: Voss Value Master Fund, L.P.
Footnotes
F1, F2, F4
RNTX holding

Common Stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
500,000
Date
14 Nov 2025
Ownership
By: Voss Value-Oriented Special Situations Fund, L.P.
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This Form 4 is filed jointly by Voss Value Master Fund, LP ("Voss Value Master Fund"), Voss Value-Oriented Special Situations Fund, LP ("Voss Value-Oriented Special Situations Fund"), Voss Advisors GP, LLC ("Voss GP"), Voss Capital, LP ("Voss Capital") and Travis W. Cocke (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Footnote F2

Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund.

Footnote F3

Securities owned directly by Voss Value-Oriented Special Situations Fund. Voss GP, as the general partner of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Voss Capital, as the investment manager of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund.

Footnote F4

Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1800 to $1.2500, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .